The Decline of Clinical Trials in Central and Eastern Europe Central and Eastern Europe participates in about 13% of clinical trials conducted in Europe and in about 5% of those conducted globally. However, this number was as high as 7.5% in 2006. In relative terms, the decline here goes as far as 28% over the last six years...Read more
Value-Based Assessment in the UK: The Industry View In March, the National Institute for Health and Care Excellence (NICE) set out its approach to Value-Based Assessment (VBA), which has evolved from what was long called Value-Based Pricing (VBA). The proposals weren’t greeted with much joy back then. With a further three months to reflect and the consultation closed, what does industry make of it all now? Leela Barham reports ... Read more
Making the Most of Social Media (Within the FDA’s New Guidelines) Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged in the U.S. since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into the social media pool, writes Ken Ribotsky ... Read more
Pharm Exec’s Top 50 Pharma Companies The vigorous return of M&A activity to biopharmaceuticals this year begs the question: is more size and scalable efficiencies the best solution to the declining market power of pharmaceuticals in an endlessly restructuring healthcare system? Our latest annual iteration of the Pharma 50 rankings confirms that the answer to this is ‘no’... Read more
Gauging the Impact of Comparative Effectiveness Research At the 50th DIA Annual Meeting in June, Pharm Exec spoke with Nancy Dreyer, chief of scientific affairs and senior VP at Quintiles Outcome, about the current tide for comparative effectiveness research (CER). Dreyer is the leader of the GRACE Initiative, which has developed good practice principles for observational studies of comparative effectiveness ... Read more
